| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2009 | WO2009050136A2 Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome |
| 04/23/2009 | WO2009050085A1 Liquid edible composition comprising isoflavones |
| 04/23/2009 | WO2009049961A2 New no-donor aspirin derivatives |
| 04/23/2009 | WO2009049917A1 Kit ligand for use in the treatment of beta-thalassaemia |
| 04/23/2009 | WO2009049900A1 Novel nutraceutical compositions containing thymol and/or p-cymene or plant extracts for cognition |
| 04/23/2009 | WO2009049820A2 Amorphous formulation |
| 04/23/2009 | WO2009049791A2 Radiolabeled nk3 receptor antagonist |
| 04/23/2009 | WO2009049743A1 5-cyano-thienopyridines for the treatment of tumors |
| 04/23/2009 | WO2009049731A1 Imidazo[1,2-a]pyrimidine derivatives for treating diseases such as diabetes |
| 04/23/2009 | WO2009049648A2 Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof |
| 04/23/2009 | WO2009049643A1 Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof |
| 04/23/2009 | WO2009049642A1 Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof |
| 04/23/2009 | WO2009049525A1 Oxazinocamptothecin derivatives and their preparation and use |
| 04/23/2009 | WO2009049495A1 Crystalline imidazol-5-carboxylic acid derivate |
| 04/23/2009 | WO2009049492A1 N-substituted aromatic hydrocarbon aniline and multi-substituted diarylether compounds, the preparation and the use of antitumor thereof |
| 04/23/2009 | WO2009049491A1 Substituted diphenylamines as inhibitors of reverse transcriptase, process of preparing them and use thereof |
| 04/23/2009 | WO2009049490A1 Use of aminoglycoside antibiotic in the preparation of pharmaceutical composition for treating drug-resistant bacterial infection |
| 04/23/2009 | WO2009049479A1 Polymorphs of donepezil salts, preparation methods and uses thereof |
| 04/23/2009 | WO2009049460A1 New packaging material for sevoflurane |
| 04/23/2009 | WO2009049439A1 Preparative method of dihydrocucurbitacin f-25-o-acetate and the use thereof in the manufacture of medicaments for treating cancers |
| 04/23/2009 | WO2009049428A1 Alpha-amylase inhibitors: the montbretins and uses thereof |
| 04/23/2009 | WO2009049422A1 Compositions and methods for enhancing enzyme activity in gaucher, gm1 -gangliosidosis/morquio b disease. and parkinson's disease |
| 04/23/2009 | WO2009049421A1 Compositions and methods for enhancing enzyme activity in gaucher, gm1-gangliosidosis/morquio b disease, and parkinson's disease |
| 04/23/2009 | WO2009049410A1 Clioquinol for the treatment of hematological malignancies |
| 04/23/2009 | WO2009049406A1 Use of ps20 /wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | WO2009049405A1 Bilayer composition for the sustained release of acetaminophen and tramadol |
| 04/23/2009 | WO2009049378A1 Lactone derivatives |
| 04/23/2009 | WO2009049370A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | WO2009049362A1 A1 adenosine receptor allosteric enhancers |
| 04/23/2009 | WO2009049354A1 Controlled-release pharmaceutical formulation |
| 04/23/2009 | WO2009033094A3 Antibodies and related molecules that bind to 24p4c12 proteins |
| 04/23/2009 | WO2009033027A3 Suppression of scn9a gene expression and/or function for the treatment of pain |
| 04/23/2009 | WO2009032558A3 Preparation of ziprasidone hydrochloride monohydrate |
| 04/23/2009 | WO2009032246A3 Particulate compositions for delivery of poorly soluble drugs |
| 04/23/2009 | WO2009032057A3 Method for the selective therapy of disease |
| 04/23/2009 | WO2009030890A9 Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma |
| 04/23/2009 | WO2009029762A3 Farnesylamine inhibitors of the visual cycle |
| 04/23/2009 | WO2009028989A3 Overweight treatment method |
| 04/23/2009 | WO2009027823A3 Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. |
| 04/23/2009 | WO2009027820A3 Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
| 04/23/2009 | WO2009027766A3 New crystalline solid forms of o-desvenlafaxine base |
| 04/23/2009 | WO2009027736A3 2,4 diaminopyrimid'lnes for the treatment of myeloproliferative disorders and cancer |
| 04/23/2009 | WO2009026414A3 Novel application of topical anesthetics for modulation of neurogenic tremor |
| 04/23/2009 | WO2009026375A3 Spermicidal and microbicidal compositions |
| 04/23/2009 | WO2009026257A3 Methods and compositions for controlling the bioavailability of poorly soluble drugs |
| 04/23/2009 | WO2009025914A3 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 04/23/2009 | WO2009024686A3 Novel method for producing dry hydrodispersible pharmaceutical forms |
| 04/23/2009 | WO2009024670A3 Hyaluronic acid injectable gel for treating joint degeneration |
| 04/23/2009 | WO2009024667A3 Antitumour combinations containing a vegf inhibiting agent and irinotecan |
| 04/23/2009 | WO2009023473A9 Antimicrobial parenteral formulation |
| 04/23/2009 | WO2009023191A3 An improved process for the preparation of clarithromycin |
| 04/23/2009 | WO2009021521A3 Use of gaboxadol for the manufacture of a medicament for treating stress-mediated depression |
| 04/23/2009 | WO2009021082A3 Phosphaplatins and their use in the treatment of cancers resistant to cisplantin and carboplatin |
| 04/23/2009 | WO2009018511A3 Alpha7 nachr agonists for treating or preventing metabolic disorders |
| 04/23/2009 | WO2009018389A4 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 04/23/2009 | WO2009017822A3 Pi3 kinase modulators and methods of use |
| 04/23/2009 | WO2009017719A3 Modulators of ccr9 receptor and methods of use thereof |
| 04/23/2009 | WO2009015164A3 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/23/2009 | WO2009013915A8 Inhibitor of plasminogen activator inhibitor-1 |
| 04/23/2009 | WO2009013211A3 New pyrazol derivatives |
| 04/23/2009 | WO2009011924A9 Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy |
| 04/23/2009 | WO2009011889A4 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 04/23/2009 | WO2009009393A4 Chromium complexes for improvement of memory and cognitive function |
| 04/23/2009 | WO2009008924A3 Methods of preventing and treating viral infections by inhibiting the deisgylation activity of otu domain-containing viral proteins |
| 04/23/2009 | WO2009007751A3 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 04/23/2009 | WO2009007748A3 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 04/23/2009 | WO2009004383A3 Aza-bicyclohexane compounds useful as anticoagulants |
| 04/23/2009 | WO2009004322A3 Derivatives of nystatin and their use as antifungal agents |
| 04/23/2009 | WO2009004171A3 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 04/23/2009 | WO2009002423A3 Polycyclic guanine derivatives and use thereof |
| 04/23/2009 | WO2009001060A3 Use of compounds for preparing anti-tuberculosis agents |
| 04/23/2009 | WO2008156654A3 Cytoskeleton modulators for treating metabolic disorders |
| 04/23/2009 | WO2008152347A3 Pack of medicinal tablets |
| 04/23/2009 | WO2008152094A3 Substituted acetamides as modulators of the ep2 receptor |
| 04/23/2009 | WO2008152014A3 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases |
| 04/23/2009 | WO2008151170A3 Process for the synthesis of ramelteon and its intermediates |
| 04/23/2009 | WO2008139271A3 A synergistic pharmaceutical combination for the treatment of cancer |
| 04/23/2009 | WO2008138658A3 Pharmaceutical compounds comprising abasic oligonucleotides |
| 04/23/2009 | WO2008133896A3 Dual-acting antihypertensive agents |
| 04/23/2009 | WO2008131501A3 New anti-viral nucleoside analogs |
| 04/23/2009 | WO2008131469A3 Method for the production of highly pure 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions containing the same, and agent formulations containing tolperisone |
| 04/23/2009 | WO2008122473A3 Food supplement containing alpha-keto acids |
| 04/23/2009 | WO2008109350A4 Nucleic acid compounds for inhibiting il6 gene expression and uses thereof |
| 04/23/2009 | WO2008107301A3 Rapid-disintegration monolayer film for the oral administration of active substances |
| 04/23/2009 | WO2008101195A3 Drug resistance reversal in neoplastic disease |
| 04/23/2009 | WO2008096377A3 Stable atorvastatin formulations |
| 04/23/2009 | WO2008075366A3 Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof |
| 04/23/2009 | WO2008068299A3 Hydrobromide salt of an anti-hiv compound |
| 04/23/2009 | WO2008065514A3 Pharmaceutical compositions containing anhydrous calcipotriene |
| 04/23/2009 | WO2008065485A3 Stable pharmaceutical compositions of a calcium channel blocker and an ace inhibitor |
| 04/23/2009 | WO2008062274A3 Pharmaceutical formulations of nsaids for parentral use |
| 04/23/2009 | WO2008062273A3 Solid oral dosage form having antidiabetic drug combination |
| 04/23/2009 | WO2008059501A3 Use of lipid conjugates in the treatment of diseases or disorders of the eye |
| 04/23/2009 | WO2008057780A3 Transdermal delivery of ketoprofen polar derivatives |
| 04/23/2009 | WO2008053295A3 Pharmaceutical compositions of benzoquinolizine-2-carboxylic acid |
| 04/23/2009 | WO2008038122A3 Processes for the preparation of 7-substituted 3,3-dimethyl-4-amino-piperidino-quinolone carboxylic acid derivatives |
| 04/23/2009 | WO2008035192A3 Method of preparation of amorphous rabeprazole sodium |
| 04/23/2009 | WO2008023248A3 Novel macrolides and ketolides having antimicrobial activity |
| 04/23/2009 | WO2008020314A3 Statin stabilizing dosage formulations |
| 04/23/2009 | WO2008010087A3 Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof |